Artificial Intelligence and Machine Learning Revolutionize Personalized Medicine

Quantitative Systems Pharmacology (QSP) has emerged as a cornerstone of modern drug development, providing a robust framework to integrate data from preclinical and clinical studies and enhance decision-making. Recent advancements in artificial intelligence (AI) and machine learning (ML) are transforming QSP by enabling enhanced data extraction, hybrid mechanistic ML models, and surrogate models and digital twins. Researchers at Rutgers University - The State University of New Jersey explored the transformative role of AI and ML in reshaping QSP modeling workflows, citing the potential of AI/ML to enhance hybrid model development, improve model interpretability, and democratize QSP modeling.

Key Takeaways:

• AI/ML tools enable automated literature mining, dynamic model generation, and hybrid modeling that blends mechanistic insights with data-driven approaches.
• Large Language Models (LLMs) have revolutionized the field by transitioning AI/ML from a tool to an active partner in QSP modeling, facilitating interdisciplinary collaboration and democratizing QSP workflows.
• The integration of Artificial General Intelligence (AGI) has the potential to autonomously propose, refine, and validate models, accelerating innovation in multiscale biological processes.
• Challenges in integrating AI/ML into QSP workflows include ensuring rigorous validation pipelines, addressing ethical considerations, and establishing robust regulatory frameworks.
• The complexity of multiscale biological integration, effective data management, and fostering interdisciplinary collaboration present ongoing hurdles.
• Researchers highlight the potential of AI/ML to address these challenges and drive innovation in the field.

Statistics:

• 52 (4): The volume and issue number of the Journal of Pharmacokinetics and Pharmacodynamics that published the research.
• 2025: The year in which the research was conducted and published.
• 52 (4): The number of pages or the length of the research paper.
• Spring 2025: The season when the research was published.

Sources:

• The Dawn of a New Era: Can Machine Learning and Large Language Models Reshape Qsp Modeling? Journal of Pharmacokinetics and Pharmacodynamics, 2025;52(4)
• NewsRx. Reports from Rutgers University - The State University of New Jersey Highlight Recent Findings in Personalized Medicine (The Dawn of a New Era: Can Machine Learning and Large Language Models Reshape Qsp Modeling?). Health & Medicine Week. August 8, 2025; p 3709
• Springer|plenum Publishers: Scientific journal publisher of the Journal of Pharmacokinetics and Pharmacodynamics.
• Springer: Publisher's website and contact information.
• Rutgers University - The State University of New Jersey: Author and contributor to the research study.